Selected Tag: NATCO Pharma
Selected Tag: NATCO Pharma

Natco Pharma gets US FDA Form 483 with seven observations at Chennai API unit

BasisPoint Insight

November 25, 2025 at 10:03 AM IST

Court Unquote

Green crackers, Sahara-SEBI, Digital Arrest, Asian Paints, and more

Your weekly rundown of significant judicial rulings and legal battles influencing policy, companies, regulation, and governance.

BasisPoint Insight

October 20, 2025 at 5:35 AM IST

Article related image

iStock.com

Natco Pharma Shareholders Approve Adcock Ingram Stake Purchase

BasisPoint Insight

October 14, 2025 at 6:00 AM IST

Lupin and Natco Launch Generic Bosentan in US with 180-Day Exclusivity

BasisPoint Insight

August 21, 2025 at 2:44 AM IST

Natco Pharma April-June Net Profit Falls 28% On Year to ₹4.81 Billion

BasisPoint Insight

August 12, 2025 at 10:24 AM IST

NATCO Pharma to Invest ₹41 Billion in South Africa Expansion

BasisPoint Insight

July 25, 2025 at 4:13 AM IST

US FDA Issues 7 Observations To Natco Pharma’s Kothur Unit

BasisPoint Insight

June 20, 2025 at 9:21 AM IST

Natco Pharma Gets One USFDA Observation For Hyderabad API unit

BasisPoint Insight

June 16, 2025 at 9:39 AM IST

Natco Pharma January-March Profit Rises 5% But Misses Estimates; Revenue Up 14%

BasisPoint Insight

May 30, 2025 at 9:08 AM IST

Natco’s Cut-Price Cure Has A Premium Twist

A complex drug priced 99.9% below the original might just lift this stock’s value perception.

Dev Chandrasekhar

April 9, 2025 at 5:26 AM IST

Article related image

iStock.com/Rawf8

Natco Pharma To Price Generic Risdiplam At ₹15,900 In India

BasisPoint Insight

April 8, 2025 at 7:19 AM IST

The Bureau

Sundeep Sikka on Building Team at Nippon MF & the Future of Mutual Funds | Market Makers Part - II
Jallikattu: Tamil Nadu’s Ancient Bull-Taming Tradition
Image